{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:52:53Z","timestamp":1769640773155,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007667","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T00:00:00Z","timestamp":1280880000000}}],"reference-count":99,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007667.pub2","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T11:24:22Z","timestamp":1280316262000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pharmacological interventions for antisocial personality disorder"],"prefix":"10.1002","author":[{"given":"Najat","family":"Khalifa","sequence":"first","affiliation":[{"name":"The Wells Road Centre; Low Secure & Community Forensic Directorate; Nottingham UK NG3 3AA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Duggan","sequence":"additional","affiliation":[{"name":"Institute of Mental Health; Section of Forensic Mental Health; Nottinghamshire Healthcare Trust, Room B06, The Gateway Building University of Nottingham, Innovation Park, Triumph Road Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Stoffers","sequence":"additional","affiliation":[{"name":"& Department of Psychiatry and Psychotherapy; Department of Psychiatry and Psychotherapy, Freiburg; Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Huband","sequence":"additional","affiliation":[{"name":"Institute of Mental Health; Section of Forensic Mental Health; Nottinghamshire Healthcare Trust, Room B06, The Gateway Building University of Nottingham, Innovation Park, Triumph Road Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit A","family":"V\u00f6llm","sequence":"additional","affiliation":[{"name":"Institute of Mental Health; Section of Forensic Mental Health; Nottinghamshire Healthcare Trust, Room B06, The Gateway Building University of Nottingham, Innovation Park, Triumph Road Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ferriter","sequence":"additional","affiliation":[{"name":"Nottinghamshire Healthcare NHS Trust; Literature and Evidence Research Unit (LERU), Institute of Mental Health; The Clair Chilvers Centre Rampton Hospital Woodbeck Nottinghamshire UK DN22 0PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Lieb","sequence":"additional","affiliation":[{"name":"University Medical Center Mainz; Department of Psychiatry and Psychotherapy; Untere Zahlbacherstr 8 Mainz Germany D-55131"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"key":"10.1002\/14651858.CD007667.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archpsyc.1992.01820110052008","article-title":"Controlled study of desipramine treatment of cocaine dependence in methadone treated patients","volume":"49","author":"Arndt","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00005053-199403000-00004","article-title":"Desipramine treatment for cocaine dependence: role of antisocial personality disorder","volume":"182","author":"Arndt","year":"1994","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Barratt ES Stanford MS Felthous AR Kent TA The effects of phenytoin on impulsive and premeditated aggression: a controlled study Journal of Clinical Psychopharmacology 1997 341 9","DOI":"10.1097\/00004714-199710000-00002"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-3223(96)00175-8","article-title":"Neuropsychological and cognitive psychophysiological substrates of impulsive aggression","volume":"41","author":"Barratt","year":"1997","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.npp.1300153","article-title":"Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0376-8716(94)90107-4","article-title":"Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence","volume":"35","author":"Leal","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1530-0277.1995.tb01532.x","article-title":"A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders","volume":"19","author":"Powell","year":"1995","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10550490701643336","article-title":"The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders","volume":"16","author":"Ralevski","year":"2007","journal-title":"American Journal on Addictions"},{"issue":"2-3","key":"10.1002\/14651858.CD007667.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-1781(01)00287-6","article-title":"A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression","volume":"103","author":"Stanford","year":"2001","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1037\/1064-1297.13.1.72","article-title":"A comparison of anticonvulsants in the treatment of impulsive aggression","volume":"13","author":"Stanford","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00004714-200012000-00010","article-title":"Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy","volume":"20","author":"Aberg-Wistedt","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0327(01)00393-7","article-title":"Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression","volume":"71","author":"Agosti","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/000276427602000204","article-title":"Sociopathy: An experiment in internal environmental control","volume":"20","author":"Allen","year":"1976","journal-title":"American Behavioural Scientist"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub2-BIB0015|cit15","first-page":"367","article-title":"A double-blind placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients","volume":"26","author":"Alpert","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004850-199911000-00007","article-title":"Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department","volume":"14","author":"Battaglia","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)90131-7","article-title":"Predictors of short-term treatment response in 66 patients with panic disorder","volume":"30","author":"Black","year":"1994","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archpsyc.1997.01830240035005","article-title":"Fluoxetine and impulsive aggressive behaviour in personality-disordered subjects","volume":"54","author":"Coccaro","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004850-199809000-00003","article-title":"Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram","volume":"13","author":"Ekselius","year":"1998","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.107.037234","article-title":"Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder","volume":"192","author":"Fournier","year":"2008","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/comp.2003.50001","article-title":"Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome","volume":"44","author":"Joyce","year":"2003","journal-title":"Comprehensive Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0022|cit22","first-page":"361","article-title":"Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy [Dutch]","volume":"49","author":"Kool","year":"2007","journal-title":"Tijdschrift voor Psychiatrie"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1176\/jnp.2.2.159","article-title":"Comparative effectiveness of carbamazepine and propranolol for rage outbursts","volume":"2","author":"Mattes","year":"1990","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.jcp.0000186739.22395.6b","article-title":"Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"25","author":"Mattes","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4088\/JCP.v69n0218","article-title":"Levetiracetam in patients with impulsive aggression: A double-blind, placebo-controlled trial","volume":"69","author":"Mattes","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2004.11.044","article-title":"Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study","volume":"57","author":"Nickel","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-440X(91)90076-O","article-title":"Personality traits associated with panic disorder: change associated with treatment","volume":"32","author":"Noyes","year":"1991","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.167.3.324","article-title":"The Edinburgh Primary Care Depression Study: personality disorder and outcome","volume":"167","author":"Patience","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1176\/ajp.147.6.711","article-title":"Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program","volume":"147","author":"Shea","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1176\/appi.ajp.157.9.1436","article-title":"Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality","volume":"157","author":"Hellerstein","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/ajp.155.4.543","article-title":"Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression","volume":"155","author":"Verkes","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"7066","key":"10.1002\/14651858.CD007667.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewedness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0033|cit33","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0034|cit34","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders -Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archpsyc.1992.01820110052008","article-title":"Controlled study of desipramine treatment of cocaine dependence in methadone treated patients","volume":"49","author":"Arndt","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","article-title":"The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome","volume":"5","author":"Attkisson","year":"1982","journal-title":"Evaluation and Program Planning"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-3223(96)00175-8","article-title":"Neuropsychological and cognitive psychophysiological substrates of impulsive aggression","volume":"41","author":"Barratt","year":"1997","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0033-3182(96)71579-7","article-title":"Death rates in 71 men with antisocial personality disorder: A comparison with general population mortality","volume":"37","author":"Black","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.71.6.727","article-title":"Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy","volume":"71","author":"Blair","year":"2001","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD007667.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2005.09.033","article-title":"The neuropsychopharmacology of aggression and addiction","volume":"526","author":"Bond","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The Aggression Questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archpsyc.1996.01830060075010","article-title":"Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet","volume":"53","author":"Coccaro","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archpsyc.55.8.708","article-title":"Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects","volume":"55","author":"Coccaro","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1192\/bjp.188.5.423","article-title":"Prevalence and correlates of personality disorder in Great Britain","volume":"188","author":"Coid","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archpsyc.1988.01800260015002","article-title":"Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine and tranylcypromin","volume":"45","author":"Cowdry","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0046|cit46","volume-title":"Psychopathic and anti-social personality disorders: treatment and research Issues","author":"Dolan","year":"1993"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/096228020101000502","article-title":"Statistical methods for the meta-analysis of cluster randomization trials","volume":"10","author":"Donner","year":"2001","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1192\/bjp.164.5.630","article-title":"South Westminster Schizophrenia Survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset","volume":"164","author":"Duke","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL: a new facility for measurement of health-related quality of life","volume":"16","author":"EuroQoL Group","year":"1990","journal-title":"Health Policy"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0010-440X(73)90036-9","article-title":"Effects of diphenylhydantoin on anxiety and hostility in institutionalized prisoners","volume":"14","author":"Gottschalk","year":"1973","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00131746-199803000-00001","article-title":"Course and stability of personality disorders","volume":"4","author":"Grilo","year":"1998","journal-title":"Journal of Practical Psychiatry and Behavioural Health"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0056|cit56","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0058|cit58","volume-title":"Managing people with severe personality disorder","author":"Home Office and Department of Health","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003499.pub3","article-title":"Antiepileptics for aggression and associated impulsivity","author":"Huband","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb","year":"2010","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1521\/pedi.1990.4.2.173","article-title":"Lithium therapy for borderline patients","volume":"4","author":"Links","year":"1990","journal-title":"Journal of Personality Disorders"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1521\/pedi.2007.21.2.199","article-title":"A framework for integrating dimensional and categorical classifications of personality disorder","volume":"21","author":"Livesley","year":"2007","journal-title":"Journal of Personality Disorders"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0063|cit63","first-page":"215","article-title":"The Overt Aggression Scale in the study of lithium in aggressive conduct disorder","volume":"30","author":"Malone","year":"1994","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1521\/pedi.18.1.90.32768","article-title":"Recent trends in the pharmacotherapy of personality disorders","volume":"18","author":"Markovitz","year":"2004","journal-title":"Journal of Personality Disorders"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s001270050138","article-title":"The epidemiology of antisocial personality disorder","volume":"34","author":"Moran","year":"1999","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-3223(90)90660-T","article-title":"Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse","volume":"28","author":"Moss","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1176\/ajp.155.4.479","article-title":"Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse","volume":"155","author":"Myers","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/bjp.188.1.13","article-title":"Personality disorder and the outcome of depression: meta-analysis of published studies","volume":"188","author":"Newton-Howes","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0069|cit69","volume-title":"Antisocial personality disorder: treatment, management and prevention (NICE Guideline 77) www.nice.org.uk\/CG77 (accessed 28\/06\/2010)","author":"National Institute of Health and Clinical Excellence","year":"2009"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0070|cit70","volume-title":"Social Trends 34","author":"ONS","year":"2004"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0071|cit71","volume-title":"Personality Disorders Over Time: Precursors, Course, and Outcome","author":"Paris","year":"2003"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"Journal of Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10401230601163501","article-title":"A comparison of adults with antisocial personality traits with and without childhood conduct disorder","volume":"19","author":"Perdikouri","year":"2007","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.57.2.119","article-title":"Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder","volume":"57","author":"Raine","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0076|cit76","volume-title":"Working Group on Psychopathic Disorder: Report (Chairman Dr John Reed)","author":"Reed","year":"1994"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0077|cit77","article-title":"Antisocial personality","volume-title":"Psychiatric disorders in America","author":"Robins","year":"1991"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bmj.323.7306.191","article-title":"Financial cost of social exclusion: follow up study of antisocial children into adulthood","volume":"323","author":"Scott","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.133.12.1409","article-title":"The effect of lithium on impulsive aggressive behavior in man","volume":"133","author":"Sheard","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0080|cit80","volume-title":"Psychiatric morbidity among prisoners in England and Wales","author":"Singleton","year":"1998"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0006-3223(02)01325-2","article-title":"The borderline diagnosis II: biology, genetics and clinical course","volume":"51","author":"Skodol","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1176\/appi.ajp.162.10.1919","article-title":"Dimensional representations of DSM-IV personality disorders: relationships to functional impairment","volume":"162","author":"Skodol","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0083|cit83","first-page":"195","article-title":"Algorithms for pharmacological treatment of personality dimensions. Symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation","volume":"62","author":"Soloff","year":"1998","journal-title":"Bulletin of the Menninger Clinic"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0084|cit84","volume-title":"STAXI-2: State-Trait Anger Expression Inventory-2","author":"Spielberger","year":"1999"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1192\/bjp.161.2.167","article-title":"Drug treatment of the personality disorders","volume":"161","author":"Stein","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0086|cit86","first-page":"506","article-title":"An open trial of valproate in borderline personality disorder","volume":"56","author":"Stein","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1176\/jnp.2006.18.3.302","article-title":"Neurodevelopmental pathways to aggression: a model to understand and target treatment in youth","volume":"18","author":"Sugden","year":"2006","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0447.1994.tb05792.x","article-title":"Epidemiology of psychiatric disorders in Edmonton: antisocial personality disorders","volume":"376","author":"Swanson","year":"1994","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/09638230020023570-2","article-title":"A new scale (SES) to measure engagement with community mental health services","volume":"11","author":"Tait","year":"2002","journal-title":"Journal of Mental Health"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","article-title":"The prevalence of personality disorders in a community sample","volume":"58","author":"Torgensen","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1192\/apt.10.5.389","article-title":"Drug treatment for personality disorders","volume":"10","author":"Tyrer","year":"2004","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0020764005057391","article-title":"The Social Functioning Questionniare: a rapid and robust measure of perceived functioning","volume":"51","author":"Tyrer","year":"2005","journal-title":"International Journal of Social Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jpsychires.2009.07.005","article-title":"Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals","volume":"44","author":"V\u00f6llm","year":"2010","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0094|cit94","volume-title":"Review of treatments for severe personality disorder","author":"Warren","year":"2001"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.1976.01770090101010","article-title":"Assessment of social adjustment by patient self-report","volume":"33","author":"Weissman","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0096|cit96","first-page":"44","article-title":"The epidemiology of personality disorders: a 1990 update","volume":"Suppl.","author":"Weissman","year":"1993","journal-title":"Journal of Personality Disorders"},{"key":"10.1002\/14651858.CD007667.pub2-BIB0097|cit97","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization (WHO)","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401239509149022","article-title":"Divalproex sodium as a treatment for borderline personality disorder","volume":"7","author":"Wilcox","year":"1995","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1360-0443.1999.94912792.x","article-title":"A review of biological indicators of illicit drug use: practical considerations and clinical usefulness","volume":"94","author":"Wolff","year":"1999","journal-title":"Addiction"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007667.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007667.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:12:30Z","timestamp":1628547150000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007667.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,4]]},"references-count":99,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007667.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007667.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,4]]}}}